Zsolt Harsanyi, Director at Emergent BioSolutions Inc. (EBS), sold 20,694 shares at $15.05 ($311K) on 2009-07-29, disclosed to the SEC on 2009-07-30.
Scheduled sale ($311k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 4,726 | $71K | 22.8% |
| 2 | $15.00 | 12,287 | $184K | 59.3% |
| 3 | $15.01 | 154 | $2K | 0.7% |
| 4 | $15.02 | 130 | $2K | 0.6% |
| 5 | $15.03 | 295 | $4K | 1.4% |
| 6 | $15.03 | 27 |
| $406 |
| 0.1% |
| 7 | $15.04 | 1,894 | $28K | 9.2% |
| 8 | $15.05 | 694 | $10K | 3.4% |
| 9 | $15.05 | 145 | $2K | 0.7% |
| 10 | $15.05 | 215 | $3K | 1.0% |
| 11 | $15.06 | 99 | $1K | 0.5% |
| 12 | $15.07 | 4 | $60 | 0.0% |
| 13 | $15.07 | 24 | $362 | 0.1% |
| Total | $15.01 avg | 20,694 | $311K | 100% |
| Filing → |
| EBS | SELL | 2020-03-17 | $416K | — | Filing → |
| EBS | SELL | 2020-01-17 | $189K | — | Filing → |
| APVO | BUY | 2019-06-07 | $39K | — | Filing → |